{"id":"e184a110-1f85-5b2e-b1b8-c551a8d679be","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:b3-cons-sarm-axotomy-nad","predicate":"preserves","statement":"After axotomy of Sarm1-null mouse DRG neurons, re-expression of active human SARM1 restored rapid axonal NAD+ depletion, whereas E642A did not.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"d7a4f7ed-f552-531b-85ec-8dbf54d8644f","mechanism_event_label":"The catalytic mutant spared axonal NAD after experimental nerve injury.","subject":{"id":"b5fff18a-900b-5c9d-ac89-9c4994262d75","slug":"sarm1-e642a","display_name":"Human SARM1 E642A","entity_type_key":"protein_state"},"object":{"id":"3af86222-b0cf-5202-9f53-2a26b91c318f","slug":"axonal-nad-concentration","display_name":"Axonal NAD+ concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d7a4f7ed-f552-531b-85ec-8dbf54d8644f","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:b3-cons-sarm-axotomy-nad-event","event_type":"biochemical_relationship","label":"The catalytic mutant spared axonal NAD after experimental nerve injury.","description":"After axotomy of Sarm1-null mouse DRG neurons, re-expression of active human SARM1 restored rapid axonal NAD+ depletion, whereas E642A did not.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"b6f6435b-139b-5b51-945f-408ddc42ab92","slug":"sarm1","display_name":"Human SARM1","entity_type_key":"protein"},"role":"enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b5fff18a-900b-5c9d-ac89-9c4994262d75","slug":"sarm1-e642a","display_name":"Human SARM1 E642A","entity_type_key":"protein_state"},"role":"impaired_enzyme","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"8d59b8e7-8eb3-5026-bdaa-7d7b59a2ae17","slug":"mouse-sarm1-knockout","display_name":"Mouse Sarm1 knockout genotype","entity_type_key":"gene"},"role":"genetic_background","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"283ed24b-06a1-50aa-9281-df3bac6ce37e","slug":"nad-plus","display_name":"NAD+","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"3af86222-b0cf-5202-9f53-2a26b91c318f","slug":"axonal-nad-concentration","display_name":"Axonal NAD+ concentration","entity_type_key":"cellular_process"},"role":"outcome","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"cross_nutrient","value_text":"false","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/niacin-consumption-sources/sarm2017.txt\", \"locator\": \"Full text, normalized paragraph 29\", \"start_char\": 20432, \"end_char\": 22775, \"file_sha256\": \"fc30de231911f5c30425173d684495e62c725ba27c78d44592e6bc68433ef545\", \"text_sha256\": \"e75c162a4b5f51b7e6ef5e20612ed8ebfbe035a41abf81284cb055dfcf860333\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Reconstitution of Sarm1-null E13.5 mouse DRG neurons with SARM1 constructs","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Lentiviral transduction on DIV1; axotomy on DIV7","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Human protein was expressed in mouse neurons; injury model, not nutritional depletion or proof of human therapeutic benefit.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Niacin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"niacin","display_name":"Niacin (vitamin B3)","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Human construct in mouse neurons","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The catalytic mutant spared axonal NAD after experimental nerve injury.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[b3-cons-sarm2017] The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration. (2017). https://pubmed.ncbi.nlm.nih.gov/28334607/ DOI: 10.1016/j.neuron.2017.02.022","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cultured dorsal-root-ganglion axons","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"ff9ddfa0-e1c6-5612-8919-2207271b00d7","evidence_kind":"source_excerpt","locator":"Lines 733-745","start_line":733,"end_line":745,"excerpt":"### b3-cons-sarm-axotomy-nad\nAfter axotomy of Sarm1-null mouse DRG neurons, re-expression of active human SARM1 restored rapid axonal NAD+ depletion, whereas E642A did not.\nCondition category: machinery_impairment\nnutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The catalytic mutant spared axonal NAD after experimental nerve injury.\norganism: Human construct in mouse neurons\ntissue_or_cell_type: Cultured dorsal-root-ganglion axons\nexperimental_model: Reconstitution of Sarm1-null E13.5 mouse DRG neurons with SARM1 constructs\nlimitations: Human protein was expressed in mouse neurons; injury model, not nutritional depletion or proof of human therapeutic benefit.\nexposure: Lentiviral transduction on DIV1; axotomy on DIV7\ncross_nutrient: false\nevidence_span: {\"source_cache\": \"artifacts/niacin-consumption-sources/sarm2017.txt\", \"locator\": \"Full text, normalized paragraph 29\", \"start_char\": 20432, \"end_char\": 22775, \"file_sha256\": \"fc30de231911f5c30425173d684495e62c725ba27c78d44592e6bc68433ef545\", \"text_sha256\": \"e75c162a4b5f51b7e6ef5e20612ed8ebfbe035a41abf81284cb055dfcf860333\"}\n[b3-cons-sarm2017] The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration. (2017). https://pubmed.ncbi.nlm.nih.gov/28334607/ DOI: 10.1016/j.neuron.2017.02.022","model_system":"Reconstitution of Sarm1-null E13.5 mouse DRG neurons with SARM1 constructs","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [b3-cons-sarm2017] The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD+ Cleavage Activity that Promotes Pathological Axonal Degeneration. (2017). https://pubmed.ncbi.nlm.nih.gov/28334607/ DOI: 10.1016/j.neuron.2017.02.022","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"a62b7b5b-786a-57e9-85e9-67c6912a5054","stable_key":"import-a9dd23c6-978a-5755-8bd8-f29bd1fe0cda","title":"Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"a8cac59639322f74812ce12eef338c2f6c385c04cc4af6ab511fc7c972f0c2e6","revision_id":"bec8fc45-12e7-5f75-a814-5d72ed015d01","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}